FR2675508B1 - - Google Patents

Info

Publication number
FR2675508B1
FR2675508B1 FR9104787A FR9104787A FR2675508B1 FR 2675508 B1 FR2675508 B1 FR 2675508B1 FR 9104787 A FR9104787 A FR 9104787A FR 9104787 A FR9104787 A FR 9104787A FR 2675508 B1 FR2675508 B1 FR 2675508B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9104787A
Other versions
FR2675508A1 (fr
Inventor
Jean-Michel Alonso
Xavier Deramoudt Francois
Sylvie Monnet
Catherine David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TM Innovation
Original Assignee
TM Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TM Innovation filed Critical TM Innovation
Priority to FR9104787A priority Critical patent/FR2675508A1/fr
Priority to PCT/FR1992/000351 priority patent/WO1992018630A1/fr
Publication of FR2675508A1 publication Critical patent/FR2675508A1/fr
Application granted granted Critical
Publication of FR2675508B1 publication Critical patent/FR2675508B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9104787A 1991-04-18 1991-04-18 Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant. Granted FR2675508A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9104787A FR2675508A1 (fr) 1991-04-18 1991-04-18 Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant.
PCT/FR1992/000351 WO1992018630A1 (fr) 1991-04-18 1992-04-17 Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104787A FR2675508A1 (fr) 1991-04-18 1991-04-18 Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant.

Publications (2)

Publication Number Publication Date
FR2675508A1 FR2675508A1 (fr) 1992-10-23
FR2675508B1 true FR2675508B1 (fr) 1995-03-03

Family

ID=9412004

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9104787A Granted FR2675508A1 (fr) 1991-04-18 1991-04-18 Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant.

Country Status (2)

Country Link
FR (1) FR2675508A1 (fr)
WO (1) WO1992018630A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735984B1 (fr) * 1995-06-30 1997-09-19 Inst Nat Sante Rech Med Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729251D0 (en) * 1987-12-15 1988-01-27 Cogent Ltd Human cytomegalovirus protein

Also Published As

Publication number Publication date
WO1992018630A1 (fr) 1992-10-29
FR2675508A1 (fr) 1992-10-23

Similar Documents

Publication Publication Date Title
EP0536964A3 (fr)
DE4290923T1 (fr)
DE4290412T1 (fr)
EP0525335A3 (fr)
DK0576484T3 (fr)
EP0520579A3 (fr)
DK0569364T3 (fr)
ECSM91576U (fr)
DE4291112T1 (fr)
EP0514050A3 (fr)
EP0520829A3 (fr)
CN3009795S (fr)
CN3009780S (fr)
CN3009754S (fr)
AU8454191A (fr)
AU8137891A (fr)
AU8114391A (fr)
EP0493840A3 (fr)
EP0495681A3 (fr)
EP0498366A3 (fr)
EP0498462A3 (fr)
EP0502808A3 (fr)
EP0503620A3 (fr)
EP0508666A3 (fr)
AU7938591A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse